Back
Harmony Biosciences Holdings Vs. Amylyx Pharmaceuticals Industry Stock Comparison
Buy
82
HRMY
Harmony Biosciences Holdings
Last Price:
31.65
Seasonality Move:
3.71%
Sell
17
AMLX
Amylyx Pharmaceuticals
Last Price:
1.93
Seasonality Move:
89.63%
Buy
82
Harmony Biosciences Holdings (HRMY)
is a Buy
Is Harmony Biosciences Holdings a Buy, Sell or Hold?
- The current Harmony Biosciences Holdings [HRMY] share price is $31.70. The Score for HRMY is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- HRMY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
17
Amylyx Pharmaceuticals (AMLX)
is a Sell
Is Amylyx Pharmaceuticals a Buy, Sell or Hold?
- The current Amylyx Pharmaceuticals [AMLX] share price is $1.93. The Score for AMLX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- AMLX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
HRMY Stock Price Chart
What is Harmony Biosciences Holdings's stock price today?
-
The Harmony Biosciences Holdings share price today is $31.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HRMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMLX Stock Price Chart
What is Amylyx Pharmaceuticals's stock price today?
-
The Amylyx Pharmaceuticals share price today is $1.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMLX is experiencing slight selling pressure.
HRMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 56.64 | Buy |
| Chaikin Money Flow: | 371129 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.16 - 31.08) | Buy |
| Bollinger Bands (100): | (30.32 - 33.08) | Sell |
AMLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 27.96 | Sell |
| Chaikin Money Flow: | -301406 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.81 - 2.37) | Sell |
| Bollinger Bands (100): | (3.37 - 16.95) | Sell |
HRMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.95 | Buy |
| 20-day SMA: | 30.05 | Buy |
| 50-day SMA: | 31.06 | Buy |
| 200-day SMA: | 31.15 | Buy |
| 8-day EMA: | 30.97 | Buy |
| 20-day EMA: | 30.6 | Buy |
| 50-day EMA: | 30.91 | Buy |
| 200-day EMA: | 32.35 | Sell |
AMLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.94 | Sell |
| 20-day SMA: | 1.96 | Sell |
| 50-day SMA: | 4.79 | Sell |
| 200-day SMA: | 14.12 | Sell |
| 8-day EMA: | 1.95 | Sell |
| 20-day EMA: | 2.25 | Sell |
| 50-day EMA: | 4.82 | Sell |
| 200-day EMA: | 13.15 | Sell |
Harmony Biosciences Holdings Earnings Growth & HRMY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.11 per share, an increase this year of $0.64 per share, and an increase next year of $1.54 per share.
Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.96 per share, an increase next quarter of $0.09 per share, a decrease this year of $2.52 per share, and an increase next year of $0.28 per share.
Harmony Biosciences Holdings Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amylyx Pharmaceuticals Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||